Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W A Craig

Showing results (21-30 of 162) with videos related to

Pageof 17
Sort By:
Clinical Therapeutics|January 1, 1980
Single-dose pharmacokinetics of cefoperazone following intravenous administrationW A Craig
Respiratory Medicine|June 23, 2001
Have we reached the point of no return? The hidden impact of antibacterial resistance in respiratory tract infection. IntroductionW A Craig
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1993
The pharmacokinetics of cefpirome--rationale for a twelve-hour dosing regimenW A Craig
International Journal of Antimicrobial Agents|January 1, 1995
Kinetics of antibiotics in relation to effective and convenient outpatient parenteral therapyW A Craig
Diagnostic Microbiology and Infectious Disease|March 1, 1993
Qualitative susceptibility tests versus quantitative MIC testsW A Craig
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1978
Theory and practical impact of binding of antimicrobials to serum proteins and tissueW A Craig, B Suh
The American Journal of Medicine|July 31, 1984
Changing patterns of hospital infections: implications for therapy. Changing concepts and new applications of antibiotic pharmacokineticsW A Craig, B Vogelman
The Pediatric Infectious Disease Journal|March 1, 1996
Pharmacokinetics and pharmacodynamics of antibiotics in otitis mediaW A Craig, D Andes
Antimicrobial Agents and Chemotherapy|May 23, 2002
Pharmacodynamics of the new fluoroquinolone gatifloxacin in murine thigh and lung infection modelsD Andes, W A Craig
Antimicrobial Agents and Chemotherapy|September 16, 1998
In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: application to breakpoint determinationsD Andes, W A Craig
Pageof 17

Showing results (21-30 of 162) with videos related to

Sort By:
Pageof 17
Clinical Therapeutics|January 1, 1980
Single-dose pharmacokinetics of cefoperazone following intravenous administrationW A Craig
Respiratory Medicine|June 23, 2001
Have we reached the point of no return? The hidden impact of antibacterial resistance in respiratory tract infection. IntroductionW A Craig
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1993
The pharmacokinetics of cefpirome--rationale for a twelve-hour dosing regimenW A Craig
International Journal of Antimicrobial Agents|January 1, 1995
Kinetics of antibiotics in relation to effective and convenient outpatient parenteral therapyW A Craig
Diagnostic Microbiology and Infectious Disease|March 1, 1993
Qualitative susceptibility tests versus quantitative MIC testsW A Craig
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1978
Theory and practical impact of binding of antimicrobials to serum proteins and tissueW A Craig, B Suh
The American Journal of Medicine|July 31, 1984
Changing patterns of hospital infections: implications for therapy. Changing concepts and new applications of antibiotic pharmacokineticsW A Craig, B Vogelman
The Pediatric Infectious Disease Journal|March 1, 1996
Pharmacokinetics and pharmacodynamics of antibiotics in otitis mediaW A Craig, D Andes
Antimicrobial Agents and Chemotherapy|May 23, 2002
Pharmacodynamics of the new fluoroquinolone gatifloxacin in murine thigh and lung infection modelsD Andes, W A Craig
Antimicrobial Agents and Chemotherapy|September 16, 1998
In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: application to breakpoint determinationsD Andes, W A Craig
Pageof 17